This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AaiPharma Gains on FDA Action

Shares of up-and-down aaiPharma (AAII)went up Friday after the Food and Drug Administration approved its request for a broader application of its methadone product.

In late trading, the Wilmington, N.C.-based company's stock gained 97 cents, or 5.2%, to reach $19.67. The stock had risen as high as $19.90.

Analysts said Friday that although methadone is not a big contributor to aaiPharma's sales, the FDA's action comes several months earlier than had been expected. The company's injectable version of methadone is used to treat moderate to severe pain in patients for whom non-narcotic analgesics are ineffective and to temporarily treat opiate-dependent patients who can't take pills.

The company's stock has been on a mostly downward plunge in recent days due to disappointing financial results, some analysts' concerns about inventories, the faster-than-expected FDA approval of a competitor's generic version of an aaiPharma painkiller, and the departure of the company's chief operating officer for the CEO job at another drug company.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $114.64 0.00%
FB $94.06 0.00%
GOOG $629.25 0.00%
TSLA $266.28 0.00%
YHOO $37.12 0.00%

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs